Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles

Medicine and Dentistry

• Pharmacodynamics 100%
• Antidepressant 100%
• Hallucinogen 100%
• Receptor 50%
• Depressive Disorder 33%
• Drug Therapy 16%
• Clinical Trial 16%
• Prefrontal Cortex 16%
• Thalamus 16%
• Repeated Drug Dose 16%
• Therapy Effect 16%
• Cell Signaling Pathway 16%
• Clinical Population 16%
• Partial Agonist 16%
• Neuropathology 16%
• Intracellular Signaling 16%
• Brainstem 16%
• Serotonin Receptor 16%
• Raphe Nucleus 16%
• Anxiety Disorder 16%
• Neurotransmitter 16%
• Psychotomimetic 16%
• Sensory Stimulation 16%

Neuroscience

• Antidepressant 100%
• Hallucinogen 100%
• Serotonergic 50%
• Receptor 33%
• Agonist 33%
• Depressive Disorder 33%
• Neuroscience 16%
• Neurotransmitter 16%
• 5-HT2A Receptor 16%
• 5-HT Receptor 16%
• Brainstem 16%
• Prefrontal Cortex 16%
• Thalamus 16%
• Intracellular Signaling 16%
• Anxiety Disorder 16%
• Drug Therapy 16%
• Psychotomimetic 16%
• Raphe Nucleus 16%